Axsome Therapeutics AXSM Non Current Inventory And Other Assets
Non Current Inventory And Other Assets at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept axsm:NonCurrentInventoryAndOtherAssets.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's non current inventory and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's non current inventory and other assets?
- Axsome Therapeutics (AXSM) reported non current inventory and other assets of $1.76M in Q1 2026.
- How has Axsome Therapeutics's non current inventory and other assets changed year-over-year?
- Axsome Therapeutics's non current inventory and other assets increased by 84.5% year-over-year, from $955K to $1.76M.
- What does non current inventory and other assets mean?
- The net change in long-term assets that are not property or equipment.
- How do you interpret non current inventory and other assets?
- An increase indicates cash being tied up in long-term assets, while a decrease indicates a release of capital from these assets.
- How does non current inventory and other assets compare across companies?
- Varies significantly by company; in biopharma, this may relate to long-term manufacturing supply agreements or restricted deposits.